We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SDR:LSESchroders PLC Analysis

Data as of 2026-06-13 - not real-time

£583.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Schroders plc trades at 583 GBp, essentially flat on its 20‑day (582.9) and 50‑day (580.8) SMAs, indicating a solid technical base. The RSI sits at 53.9, suggesting neutral momentum, while the MACD histogram is negative (‑0.26) and the signal line is bearish, hinting at short‑term downside pressure near the resistance of 585.5. Fundamentally, the firm delivers strong profitability with a gross margin of 78% and operating margin of 35%, and revenue is growing at 15.5% YoY. The P/E of 17.1 is only marginally above the industry average of 16.8, and the dividend yield of 3.69% with a 64% payout ratio is well‑backed by robust cash generation (free cash flow > £1.2 bn). The beta of –0.12 and 30‑day volatility of 2.96% point to low market sensitivity, and the max drawdown of 11.1% has been contained. Recent Form 8 disclosures reveal no material corporate actions, so the outlook remains driven by the existing earnings and cash‑flow profile.
Overall, the stock appears fairly valued with a stable dividend, modest growth prospects, and limited downside risk, making it a candidate for accumulation over the medium to long term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near immediate resistance at 585.5
  • Bearish MACD histogram indicating short‑term pressure
  • Stable dividend yield supporting price floor

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 15.5% and strong operating margins
  • Undervalued relative to peers on P/E and robust cash flow
  • Low volatility and negative beta reducing market risk

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend with a 64% payout ratio
  • Diversified global asset base limiting geographic concentration
  • Consistent profitability and solid balance sheet (low debt-to-equity)

Key Metrics & Analysis

Financial Health

Revenue Growth15.50%
Profit Margin15.81%
P/E Ratio17.1
ROE12.30%
ROA2.29%
Debt/Equity12.87
P/B Ratio2.1
Op. Cash Flow£914.4M
Free Cash Flow£1.2B
Industry P/E16.8

Technical Analysis

TrendBullish
RSI53.9
Support£581.00
Resistance£585.50
MA 20£582.90
MA 50£580.83
MA 200£474.63
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value£2,303.27
Target Price£543.26
Upside/Downside-6.82%
GradeFair
TypeBlend
Dividend Yield3.69%

Risk Assessment

Beta-0.12
Volatility2.96%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.